Study to tell borderline from early ovarian cancer
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study uses ultrasound and blood tests to help doctors tell the difference between a borderline ovarian tumor and an early-stage invasive ovarian cancer. If you have a cyst found on your ovary that might be one of these types, joining could help improve diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You have a cyst on an ovary found by ultrasound that the doctor thinks could be a borderline or early-stage invasive tumor.
- You agree to have an ultrasound and blood sample taken before surgery.
- You are not pregnant, breastfeeding, or planning to get pregnant, and if you could become pregnant, you use highly effective birth control.
- You have not had any other cancer in the last 5 years.
- You do not have active HIV, hepatitis B, or hepatitis C.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study will collect medical information from people with advanced ovarian, peritoneal, or fallopian tube cancer. The goal is to learn more about these cancers and improve future treatments.
This study is testing a new blood test to help find ovarian cancer early in women who are at average risk. By joining, you may help improve early detection, which could lead to better outcomes.
This trial studies whether a simple blood test (liquid biopsy) can help tell if an ovarian mass is cancer or not, and if it can catch cancer early. If you're going to have surgery for a suspicious ovarian mass, this test might give extra information to guide your care.
This study is testing new blood tests that might help detect ovarian cancer earlier by looking for specific markers. It involves people with suspected ovarian cancer and healthy volunteers, and aims to improve how we diagnose the disease.
This study looks at “biomarkers,” meaning measurable signals in blood and tumor tissue, in people with advanced ovarian-type cancers. The goal is to understand these markers and how they relate to the cancer, which may help guide future care.
This study is testing a blood test that may help find ovarian cancer earlier in people with BRCA1 or BRCA2 gene changes. It involves giving blood samples before and after surgery to remove the ovaries and fallopian tubes, or over several years if you've had a precancerous lesion found.
Hear when a new Stage I Ovarian Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.